Carevature Medical Ltd. The company is focused on creating its next-generation robotic platform and promoting its suite of FDA and CE-approved Dreal® end-effectors for various spinal indications. Their goal is to establish the necessary clinical knowledge and expertise for the adoption of their full robotic decompression platform.

Carevature's products are manufactured under the highest standards and are ISO13485:2016 certified. Each unit undergoes functional testing before being released for packaging and sterilization. The management team at Carevature is comprised of experienced professionals who have made significant contributions in the medical device industry.

They have expertise in product and market development, clinical studies, regulatory compliance, quality assurance, operations, sales, and marketing. Additionally, Carevature has a distinguished Scientific Advisory Board, consisting of renowned orthopedic spine surgeons and neurosurgeons. These experts contribute to the development and validation of the company's innovative spinal surgical techniques and technologies.

In summary, Carevature Medical is a pioneering brand in the field of robotic spinal surgery, offering advanced products and services to improve patient outcomes and revolutionize the field of spinal surgery